Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...

InMode is a pioneer, first mover and leader in the field of minimally-invasive treatment and it generates mouth-watering returns. InMode is set to exceed investors' expectations embedded in today's ...

Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we'll explain below. However, now that it's down 76% from highs, ...

On September 9, 2025, DOMA Perpetual Capital Management LLC announced it had sent a letter to InMode Ltd.'s Board urging approval of a 10% share buyback in Q4 2025 and another 10% in Q1 2026, while ...

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are going to take a look at where InMode Ltd. (NASDAQ:INMD) stands against the ...

YOKNEAM, Israel, July 10, 2025 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

In 2021, it seemed as if medical technology stocks could do no wrong. Shares of cosmetic sculpting device manufacturer InMode (NASDAQ: INMD) more than doubled as enthusiasm for all things new and ...